Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-01-14
1995-05-02
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514327, A61K 3146, A61K 31445
Patent
active
054119685
ABSTRACT:
The invention relates to the use of compounds which act as 5-hydroxytryptamine (5-HT) antagonists at 5-HT "M" receptors in the treatment of anxiety.
REFERENCES:
patent: 4695578 (1987-09-01), Coates et al.
patent: 4721720 (1988-01-01), Wootton et al.
patent: 4725603 (1988-02-01), Sanger et al.
patent: 4725615 (1988-02-01), Coates et al.
patent: 4749718 (1988-06-01), Coates et al.
patent: 4808581 (1989-02-01), Oxford et al.
patent: 5204356 (1993-04-01), Tyers
Iverson, Neuropharm, 1984, 23, 1553-1560.
Stein et al., Adv. Biochemical Psychopharmacology, 14, 29-44, 1975.
Glaxo Group Limited
Henley III Raymond
Jarvis William R. A.
LandOfFree
Treatment of anxiety does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of anxiety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of anxiety will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137262